REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 189 filers reported holding REATA PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 0.71 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $756,000 | -9.2% | 7,758 | +45.4% | 0.53% | -11.9% |
| Q2 2020 | $833,000 | +4.3% | 5,336 | -3.6% | 0.60% | -14.7% |
| Q1 2020 | $799,000 | +0.6% | 5,538 | +42.6% | 0.71% | +0.7% |
| Q4 2019 | $794,000 | +113.4% | 3,884 | -16.3% | 0.70% | +91.8% |
| Q3 2019 | $372,000 | -45.2% | 4,642 | -35.5% | 0.37% | -40.8% |
| Q2 2019 | $679,000 | -19.5% | 7,196 | -27.1% | 0.62% | -30.2% |
| Q1 2019 | $844,000 | +9.2% | 9,871 | -28.4% | 0.89% | +8.4% |
| Q4 2018 | $773,000 | – | 13,786 | – | 0.82% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Conrad N. Hilton Foundation | 63,481 | $7,847,000 | 100.00% |
| CPMG Inc | 2,896,901 | $358,115,000 | 55.16% |
| PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE | 140,000 | $17,307,000 | 26.62% |
| Corriente Advisors, LLC | 525,000 | $64,901,000 | 15.45% |
| DUMAC, INC. | 76,050 | $9,401,000 | 7.33% |
| MADDEN SECURITIES Corp | 35,152 | $4,345,000 | 2.80% |
| Biondo Investment Advisors, LLC | 113,692 | $14,055,000 | 2.69% |
| Duquesne Family Office | 749,897 | $92,702,000 | 2.50% |
| LBJ Family Wealth Advisors, Ltd. | 30,368 | $3,754,000 | 2.44% |
| Integral Health Asset Management, LLC | 50,000 | $6,181,000 | 1.84% |